These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 15716376

  • 1. Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53.
    Maehara K, Yamakoshi K, Ohtani N, Kubo Y, Takahashi A, Arase S, Jones N, Hara E.
    J Cell Biol; 2005 Feb 14; 168(4):553-60. PubMed ID: 15716376
    [Abstract] [Full Text] [Related]

  • 2. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
    Santoni-Rugiu E, Duro D, Farkas T, Mathiasen IS, Jäättelä M, Bartek J, Lukas J.
    Oncogene; 2002 Sep 19; 21(42):6498-509. PubMed ID: 12226753
    [Abstract] [Full Text] [Related]

  • 3. Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate.
    Ahmad N, Adhami VM, Gupta S, Cheng P, Mukhtar H.
    Arch Biochem Biophys; 2002 Feb 01; 398(1):125-31. PubMed ID: 11811957
    [Abstract] [Full Text] [Related]

  • 4. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA, Di YM, Randolph JK, Jain PT, Valerie K, Bullock S, Nath N, Chellappan SP.
    Arch Biochem Biophys; 2001 Apr 15; 388(2):243-52. PubMed ID: 11368161
    [Abstract] [Full Text] [Related]

  • 5. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
    Yamada M, Kondo T, Ashizawa S, Takebayashi T, Higashi H, Hatakeyama M.
    Cytokine; 2002 Jan 21; 17(2):91-7. PubMed ID: 11886176
    [Abstract] [Full Text] [Related]

  • 6. Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions.
    Lind EF, Wayne J, Wang QZ, Staeva T, Stolzer A, Petrie HT.
    J Immunol; 1999 May 01; 162(9):5374-9. PubMed ID: 10228014
    [Abstract] [Full Text] [Related]

  • 7. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor.
    de la Luna S, Allen KE, Mason SL, La Thangue NB.
    EMBO J; 1999 Jan 04; 18(1):212-28. PubMed ID: 9878064
    [Abstract] [Full Text] [Related]

  • 8. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
    Nip J, Hiebert SW.
    Cell Biochem Biophys; 2000 Jan 04; 33(2):199-207. PubMed ID: 11325040
    [Abstract] [Full Text] [Related]

  • 9. E2F-1-induced p53-independent apoptosis in transgenic mice.
    Holmberg C, Helin K, Sehested M, Karlström O.
    Oncogene; 1998 Jul 16; 17(2):143-55. PubMed ID: 9674698
    [Abstract] [Full Text] [Related]

  • 10. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
    Wadhwa R, Takano S, Taira K, Kaul SC.
    J Gene Med; 2004 Apr 16; 6(4):439-44. PubMed ID: 15079818
    [Abstract] [Full Text] [Related]

  • 11. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
    Sebastian T, Malik R, Thomas S, Sage J, Johnson PF.
    EMBO J; 2005 Sep 21; 24(18):3301-12. PubMed ID: 16107878
    [Abstract] [Full Text] [Related]

  • 12. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation.
    Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW.
    Oncogene; 2001 Feb 22; 20(8):910-20. PubMed ID: 11314026
    [Abstract] [Full Text] [Related]

  • 13. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.
    Obama K, Kanai M, Kawai Y, Fukushima M, Takabayashi A.
    Int J Oncol; 2002 Aug 22; 21(2):309-14. PubMed ID: 12118326
    [Abstract] [Full Text] [Related]

  • 14. P130 and its truncated form mediate p53-induced cell cycle arrest in Rb(-/-) Saos2 cells.
    Gao CF, Ren S, Wang J, Zhang SL, Jin F, Nakajima T, Ikeda M, Tsuchida N.
    Oncogene; 2002 Oct 24; 21(49):7569-79. PubMed ID: 12386819
    [Abstract] [Full Text] [Related]

  • 15. E2F target genes and cell-cycle checkpoint control.
    Lavia P, Jansen-Dürr P.
    Bioessays; 1999 Mar 24; 21(3):221-30. PubMed ID: 10333731
    [Abstract] [Full Text] [Related]

  • 16. p14ARF links the tumour suppressors RB and p53.
    Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH.
    Nature; 1998 Sep 10; 395(6698):124-5. PubMed ID: 9744267
    [No Abstract] [Full Text] [Related]

  • 17. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
    Wells J, Yan PS, Cechvala M, Huang T, Farnham PJ.
    Oncogene; 2003 Mar 13; 22(10):1445-60. PubMed ID: 12629508
    [Abstract] [Full Text] [Related]

  • 18. E2F - at the crossroads of life and death.
    Polager S, Ginsberg D.
    Trends Cell Biol; 2008 Nov 13; 18(11):528-35. PubMed ID: 18805009
    [Abstract] [Full Text] [Related]

  • 19. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 20. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
    Hershko T, Chaussepied M, Oren M, Ginsberg D.
    Cell Death Differ; 2005 Apr 12; 12(4):377-83. PubMed ID: 15706352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.